Veranova is building!

At Veranova, we’re building the advanced infrastructure needed to handle some of the most potent and complex molecules, helping our partners deliver life-saving medicines to patients around the world. Watch our latest video to see the progress we’re making at our Devens, Massachusetts facility.

First announced in June 2024, the investment will add 9,000 square feet to the Devens site, including a new state-of-the-art process development laboratory and two current Good Manufacturing Practice (cGMP) suites. These new capabilities will expand the site’s development and production capabilities for potent compounds, ADC linker-payloads, and other complex molecules critical to next generation therapeutics.

Veranova also announced a complementary investment to establish state-of-the-art bioconjugation development and cGMP manufacturing capabilities at the Devens site. Together, these initiatives represent a more than $50 million commitment to strengthening U.S.-based infrastructure for ADCs and bioconjugates, and are expected to create up to 70 new jobs.